168 related articles for article (PubMed ID: 9815962)
1. Expression of the heat shock protein HSP27 in human ovarian cancer.
Langdon SP; Rabiasz GJ; Hirst GL; King RJ; Hawkins RA; Smyth JF; Miller WR
Clin Cancer Res; 1995 Dec; 1(12):1603-9. PubMed ID: 9815962
[TBL] [Abstract][Full Text] [Related]
2. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Langdon SP; Gabra H; Bartlett JM; Rabiaz GJ; Hawkins RA; Tesdale AL; Ritchie AA; Miller WR; Smyth JF
Clin Cancer Res; 1998 Sep; 4(9):2245-51. PubMed ID: 9748145
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
5. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of the MDR1 gene and HSP27 in human ovarian cancer.
Schneider J; Jimenez E; Marenbach K; Marx D; Meden H
Anticancer Res; 1998; 18(4C):2967-71. PubMed ID: 9713493
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
Chan KK; Wei N; Liu SS; Xiao-Yun L; Cheung AN; Ngan HY
Obstet Gynecol; 2008 Jan; 111(1):144-51. PubMed ID: 18165403
[TBL] [Abstract][Full Text] [Related]
9. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients.
Oppitz M; Möbus V; Brock S; Drews U
Gynecol Oncol; 2002 Apr; 85(1):159-64. PubMed ID: 11925137
[TBL] [Abstract][Full Text] [Related]
11. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
[TBL] [Abstract][Full Text] [Related]
14. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.
Oesterreich S; Hilsenbeck SG; Ciocca DR; Allred DC; Clark GM; Chamness GC; Osborne CK; Fuqua SA
Clin Cancer Res; 1996 Jul; 2(7):1199-206. PubMed ID: 9816288
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
16. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells.
Lemieux P; Oesterreich S; Lawrence JA; Steeg PS; Hilsenbeck SG; Harvey JM; Fuqua SA
Invasion Metastasis; 1997; 17(3):113-23. PubMed ID: 9702938
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer.
Zhang D; Wong LL; Koay ES
Mol Cancer; 2007 Aug; 6():52. PubMed ID: 17697330
[TBL] [Abstract][Full Text] [Related]
18. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
19. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens.
Miller H; Poon S; Hibbert B; Rayner K; Chen YX; O'Brien ER
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):e10-4. PubMed ID: 15662019
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
Strathdee G; Vass JK; Oien KA; Siddiqui N; Curto-Garcia J; Brown R
Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
